Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • STX vs MRNA✓SelectedUSD · MRNASTX vs MRNA performance historyLatest closeAs of+1.06%11/19
Stock and ETF performance explorer

STX vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,640.0%
MRNA return
+806.0%
Excess return
+834.0%
Maximum drawdown
-57.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+1.1%+1.3%-0.2%+1.0%
7D-4.4%-13.8%+9.5%-3.8%
30D-22.8%-17.7%-5.1%-22.2%
3M-37.3%+14.3%-51.6%-37.8%
6M-28.8%+336.0%-364.8%-36.4%
YTD+89.9%+575.9%-486.0%+62.2%
1Y+102.4%+724.4%-622.0%+69.6%
3Y+629.4%+160.8%+468.6%+550.5%
5Y+496.2%-24.4%+520.6%+458.9%
All+1,640.0%+806.0%+834.0%+1,380.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling